The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mycology Immunoassays Testing Market Research Report 2024
Synopsis
Mycology immunoassays testing is a diagnostic method used to detect fungal infections by measuring specific immune responses to fungal antigens in patient samples.
The global Mycology Immunoassays Testing market was valued at US$ 1795.7 million in 2023 and is anticipated to reach US$ 2605.3 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
This report aims to provide a comprehensive presentation of the global market for Mycology Immunoassays Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycology Immunoassays Testing.
Report Scope
The Mycology Immunoassays Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycology Immunoassays Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycology Immunoassays Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Segment by Type
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Segment by Application
Hospitals
Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycology Immunoassays Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Mycology immunoassays testing is a diagnostic method used to detect fungal infections by measuring specific immune responses to fungal antigens in patient samples.
The global Mycology Immunoassays Testing market was valued at US$ 1795.7 million in 2023 and is anticipated to reach US$ 2605.3 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The market for mycology immunoassays testing is driven by the need for accurate and timely diagnosis of fungal infections, which can have serious consequences if left untreated. The market's growth is also influenced by the increasing prevalence of fungal infections, particularly in immunocompromised individuals, and advancements in immunoassay technology, leading to improved sensitivity and specificity of fungal diagnostic tests.
This report aims to provide a comprehensive presentation of the global market for Mycology Immunoassays Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycology Immunoassays Testing.
Report Scope
The Mycology Immunoassays Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycology Immunoassays Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycology Immunoassays Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation
Segment by Type
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)
Segment by Application
Hospitals
Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycology Immunoassays Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycology Immunoassays Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA
1.2.3 Rapid Tests
1.2.4 ELISPOT
1.2.5 Polymerase Chain Reaction (PCR)
1.3 Market by Application
1.3.1 Global Mycology Immunoassays Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Blood Banks
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mycology Immunoassays Testing Market Perspective (2019-2030)
2.2 Mycology Immunoassays Testing Growth Trends by Region
2.2.1 Global Mycology Immunoassays Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycology Immunoassays Testing Historic Market Size by Region (2019-2024)
2.2.3 Mycology Immunoassays Testing Forecasted Market Size by Region (2025-2030)
2.3 Mycology Immunoassays Testing Market Dynamics
2.3.1 Mycology Immunoassays Testing Industry Trends
2.3.2 Mycology Immunoassays Testing Market Drivers
2.3.3 Mycology Immunoassays Testing Market Challenges
2.3.4 Mycology Immunoassays Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mycology Immunoassays Testing Players by Revenue
3.1.1 Global Top Mycology Immunoassays Testing Players by Revenue (2019-2024)
3.1.2 Global Mycology Immunoassays Testing Revenue Market Share by Players (2019-2024)
3.2 Global Mycology Immunoassays Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mycology Immunoassays Testing Revenue
3.4 Global Mycology Immunoassays Testing Market Concentration Ratio
3.4.1 Global Mycology Immunoassays Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycology Immunoassays Testing Revenue in 2023
3.5 Mycology Immunoassays Testing Key Players Head office and Area Served
3.6 Key Players Mycology Immunoassays Testing Product Solution and Service
3.7 Date of Enter into Mycology Immunoassays Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mycology Immunoassays Testing Breakdown Data by Type
4.1 Global Mycology Immunoassays Testing Historic Market Size by Type (2019-2024)
4.2 Global Mycology Immunoassays Testing Forecasted Market Size by Type (2025-2030)
5 Mycology Immunoassays Testing Breakdown Data by Application
5.1 Global Mycology Immunoassays Testing Historic Market Size by Application (2019-2024)
5.2 Global Mycology Immunoassays Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Mycology Immunoassays Testing Market Size (2019-2030)
6.2 North America Mycology Immunoassays Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Mycology Immunoassays Testing Market Size by Country (2019-2024)
6.4 North America Mycology Immunoassays Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Mycology Immunoassays Testing Market Size (2019-2030)
7.2 Europe Mycology Immunoassays Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Mycology Immunoassays Testing Market Size by Country (2019-2024)
7.4 Europe Mycology Immunoassays Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mycology Immunoassays Testing Market Size (2019-2030)
8.2 Asia-Pacific Mycology Immunoassays Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Mycology Immunoassays Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Mycology Immunoassays Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Mycology Immunoassays Testing Market Size (2019-2030)
9.2 Latin America Mycology Immunoassays Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Mycology Immunoassays Testing Market Size by Country (2019-2024)
9.4 Latin America Mycology Immunoassays Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mycology Immunoassays Testing Market Size (2019-2030)
10.2 Middle East & Africa Mycology Immunoassays Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Mycology Immunoassays Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Mycology Immunoassays Testing Introduction
11.1.4 Roche Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Mycology Immunoassays Testing Introduction
11.2.4 Abbott Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Mycology Immunoassays Testing Introduction
11.3.4 Siemens Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.3.5 Siemens Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Mycology Immunoassays Testing Introduction
11.4.4 Beckman Coulter Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Ortho-Clinical Diagnostics
11.5.1 Ortho-Clinical Diagnostics Company Detail
11.5.2 Ortho-Clinical Diagnostics Business Overview
11.5.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Introduction
11.5.4 Ortho-Clinical Diagnostics Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.5.5 Ortho-Clinical Diagnostics Recent Development
11.6 bioMérieux
11.6.1 bioMérieux Company Detail
11.6.2 bioMérieux Business Overview
11.6.3 bioMérieux Mycology Immunoassays Testing Introduction
11.6.4 bioMérieux Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.6.5 bioMérieux Recent Development
11.7 ELITechGroup
11.7.1 ELITechGroup Company Detail
11.7.2 ELITechGroup Business Overview
11.7.3 ELITechGroup Mycology Immunoassays Testing Introduction
11.7.4 ELITechGroup Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.7.5 ELITechGroup Recent Development
11.8 MiraVista Diagnostics
11.8.1 MiraVista Diagnostics Company Detail
11.8.2 MiraVista Diagnostics Business Overview
11.8.3 MiraVista Diagnostics Mycology Immunoassays Testing Introduction
11.8.4 MiraVista Diagnostics Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.8.5 MiraVista Diagnostics Recent Development
11.9 Autobio Diagnostics CO.,Ltd.
11.9.1 Autobio Diagnostics CO.,Ltd. Company Detail
11.9.2 Autobio Diagnostics CO.,Ltd. Business Overview
11.9.3 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Introduction
11.9.4 Autobio Diagnostics CO.,Ltd. Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.9.5 Autobio Diagnostics CO.,Ltd. Recent Development
11.10 CapitalBio Corporation
11.10.1 CapitalBio Corporation Company Detail
11.10.2 CapitalBio Corporation Business Overview
11.10.3 CapitalBio Corporation Mycology Immunoassays Testing Introduction
11.10.4 CapitalBio Corporation Revenue in Mycology Immunoassays Testing Business (2019-2024)
11.10.5 CapitalBio Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
